Model parameters: baseline values, ranges, and distributions for sensitivity analysis.

مواد مشابهة

• Base-case results.
  حسب: Ping Chen (89712)
  منشور في: (2025)
• Summary of the goodness of statistical fit of the KM curve in the TORCHLIGHT trial.
  حسب: Ping Chen (89712)
  منشور في: (2025)
• Cost-effectiveness acceptability curve for comparisons among various treatment regimens.
  حسب: Ping Chen (89712)
  منشور في: (2025)
• One-way sensitivity analysis tornado diagram of the incremental cost–effectiveness ratio (cost per quality-adjusted life-year) of toripalimab plus chemotherapy versus chemotherapy. cT, cost per cycle of toripalimab; uPfs, utility of subsequent free survival cycle; uPD, utility of progressive disease; cSt, cost of subsequent treatment per cycle after disease progression; cNab, cost per cycle of nab-paclitaxel; PPNe, probability of care in the PN group; cTcpa, utility of neutropenia per cycle; PTNNe, probability of care in the T+  N group; experiencing terminal cost cBs, carboplatin body surface area (m²); cN, cost per cycle of neutropenia; PTNLe, probability of experiencing leukopenia in the T +  N group; PPNLe, probability of experiencing leukopenia in the PN group; cCt, cost of CT scan; cTi, cost of tumor imaging; ucost, cost of leukopenia; uNe, cost of leukopenia; cL, cost of leukopenia; cC, cost of utility (1 mg); cG, cost of gemcitabine; cLt, cost of laboratory testing.
  حسب: Ping Chen (89712)
  منشور في: (2025)
• Decision tree and model structure overview.
  حسب: Ping Chen (89712)
  منشور في: (2025)